Back to BlackRock, Inc.SYRE
SYRE6 quarters
Position history for BlackRock, Inc.'s holdings in SPYRE THERAPEUTICS INC
BlackRock, Inc. holds 5.5M shares of SYRE (SPYRE THERAPEUTICS INC), worth $278.5M as of 2026-Q1. The position was decreased (-0.0% shares). SYRE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$278.5M
Current Shares
5.5M
Total Value Change
+$199.3M
Total Shares Change
+2.1M
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, RTW INVESTMENTS, LP, VANGUARD CAPITAL MANAGEMENT LLC